SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?


To: gao seng who wrote (2181)12/7/1999 8:31:00 AM
From: Monsieur Bouledogue  Respond to of 3576
 
GERN on www.dayinvestor.com



To: gao seng who wrote (2181)12/7/1999 10:50:00 AM
From: Savant  Respond to of 3576
 
Geron has an extensive portfolio of issued patents and pending patent
applications relating to telomerase and telomerase inhibition. On
September 28, 1999, the US Patent Office issued U.S. patent No. 5,958,
680 to Geron, with claims relating to methods of inhibiting telomerase
activity in human cells using inhibitors of the type used in the
University of Texas Southwestern Medical Center research